American Association for the Advancement of Science, Science Immunology, 84(8), 2023
DOI: 10.1126/sciimmunol.adi8769
Full text: Unavailable
Endogenous retrovirus antibody responses contribute to survival after immune checkpoint blockade therapy against lung adenocarcinoma.